Clinical Trial Update: The Effects of Angle Kappa on Clinical Outcomes With the PanOptix Intraocular Lens

View source ↗

Summary

A completed clinical trial evaluating how angle kappa affects outcomes with the PanOptix intraocular lens in pseudophakic patients; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Pseudophakia

Drugs mentioned

• PanOptix (intraocular lens, multifocal toric)

Snippet

Sponsor: Carolina Eyecare Physicians, LLC | Conditions: Pseudophakia | Status: COMPLETED | Results posted: 2023-03-17